Lonza adds commercial chief from Celonic; WuXi Biologics posts revenue gain
Lonza has established a new executive role for commercial operations, appointing Samanta Cimitan, currently CEO of Celonic, to the position effective January 1. The move is intended to strengthen the company's management of customer accounts. Separately, WuXi Biologics announced a notable increase in its revenue.
Related stories
Replimune Appoints New Commercial Chief; Neumora Shakes Up Executive Ranks · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Lonza creates commercial chief position; WuXi Biologics reports revenue jump.” Browse more stories.